These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9272114

  • 1. Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells.
    Poulain L, Sichel F, Crouet H, Bureau F, Gauduchon P, Gignoux M, Le Talaër JY.
    Cancer Chemother Pharmacol; 1997; 40(5):385-90. PubMed ID: 9272114
    [Abstract] [Full Text] [Related]

  • 2. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
    Sharp SY, Mistry P, Valenti MR, Bryant AP, Kelland LR.
    Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
    [Abstract] [Full Text] [Related]

  • 3. Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells.
    Kikkawa F, Kojima M, Oguchi H, Maeda O, Ishikawa H, Tamakoshi K, Mizuno K, Kawai M, Suganuma N, Tomoda Y.
    Anticancer Res; 1993; 13(4):891-6. PubMed ID: 8352556
    [Abstract] [Full Text] [Related]

  • 4. Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells.
    Assem M, Bonvalot S, Beltramo JL, Garrido C, Dimanche-Boitrel MT, Genne P, Rebibou JM, Caillot D, Chauffert B.
    Br J Cancer; 1994 Oct; 70(4):631-5. PubMed ID: 7917908
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II.
    Ferguson PJ, Currie C, Vincent MD.
    Drug Metab Dispos; 1999 Dec; 27(12):1399-405. PubMed ID: 10570020
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide.
    Marklund L, Henriksson R, Grankvist K.
    Int J Cancer; 2001 Aug 15; 93(4):577-83. PubMed ID: 11477563
    [Abstract] [Full Text] [Related]

  • 7. Sensitisation of human ovarian carcinoma cells to cis-diamminedichloroplatinum (II) by amphotericin B in vitro and in vivo.
    Kojima M, Kikkawa F, Oguchi H, Mizuno K, Maeda O, Tamakoshi K, Ishikawa H, Kawai M, Suganuma N, Tomoda Y.
    Eur J Cancer; 1994 Aug 15; 30A(6):773-8. PubMed ID: 7917536
    [Abstract] [Full Text] [Related]

  • 8. Aphidicolin markedly increases the platinum sensitivity of cells from primary ovarian tumours.
    Sargent JM, Elgie AW, Williamson CJ, Taylor CG.
    Br J Cancer; 1996 Dec 15; 74(11):1730-3. PubMed ID: 8956785
    [Abstract] [Full Text] [Related]

  • 9. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ, Sleijfer S, Meijer C, Kampinga HH, Konings AW, De Vries EG, Mulder NH.
    Br J Cancer; 1995 Dec 15; 72(6):1406-11. PubMed ID: 8519652
    [Abstract] [Full Text] [Related]

  • 10. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS, Fanta PT, Running KL, Adair LP, Garcia DJ, Liu-Stevens R, Salmon SE.
    Cancer Chemother Pharmacol; 1997 Dec 15; 39(6):493-7. PubMed ID: 9118460
    [Abstract] [Full Text] [Related]

  • 11. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
    Harstrick A, Bokemeyer C, Scharnofkse M, Hapke G, Reile D, Schmoll HJ.
    Cancer Chemother Pharmacol; 1993 Dec 15; 33(1):43-7. PubMed ID: 8269588
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) by amphotericin B in BALB/c nude mice bearing human ovarian carcinoma cells.
    Kojima M, Kikkawa F, Oguchi H, Tamakoshi K, Maeda O, Suganuma N, Tomoda Y.
    Jpn J Cancer Res; 1994 Nov 15; 85(11):1159-64. PubMed ID: 7829402
    [Abstract] [Full Text] [Related]

  • 13. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.
    Morikage T, Ohmori T, Nishio K, Fujiwara Y, Takeda Y, Saijo N.
    Cancer Res; 1993 Jul 15; 53(14):3302-7. PubMed ID: 8391922
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
    Brooks SE, Korbut TT, Dupuis NP, Holden SA, Teicher BA.
    Cancer Chemother Pharmacol; 1995 Jul 15; 36(5):431-8. PubMed ID: 7634385
    [Abstract] [Full Text] [Related]

  • 15. Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
    Hernlund E, Hjerpe E, Avall-Lundqvist E, Shoshan M.
    Mol Cancer Ther; 2009 Jul 15; 8(7):1916-23. PubMed ID: 19567816
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.
    Holloway RW, Mehta RS, Finkler NJ, Li KT, McLaren CE, Parker RJ, Fruehauf JP.
    Gynecol Oncol; 2002 Oct 15; 87(1):8-16. PubMed ID: 12468336
    [Abstract] [Full Text] [Related]

  • 18. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
    Perez RP, O'Dwyer PJ, Handel LM, Ozols RF, Hamilton TC.
    Int J Cancer; 1991 May 10; 48(2):265-9. PubMed ID: 2019469
    [Abstract] [Full Text] [Related]

  • 19. Reversal of cisplatin resistance with amphotericin B in a non-small cell lung cancer cell line.
    Morikage T, Bungo M, Inomata M, Yoshida M, Ohmori T, Fujiwara Y, Nishio K, Saijo N.
    Jpn J Cancer Res; 1991 Jun 10; 82(6):747-51. PubMed ID: 1649814
    [Abstract] [Full Text] [Related]

  • 20. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
    Mellish KJ, Kelland LR, Harrap KR.
    Br J Cancer; 1993 Aug 10; 68(2):240-50. PubMed ID: 8347478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.